Economically feasible induction of the bacteriophage λQ- mutant in Escherichia coli

Bioprocess Engineering

Volumn 20, Issue 2, 1999, Pages 105-108

  Flórez, Angeles ^a,b   Sánchez Aguilar, Dolores ^a   Peteiro, Carmen ^a   Suárez Peñaranda, José M ^a   Toribio, Jaime ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIOPHAGE; BIOTECHNOLOGY; COST EFFECTIVENESS ANALYSIS; CYTOLYSIS; DNA PACKAGING; ENZYME SYNTHESIS; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE SENSITIVE MUTANT;

ESCHERICHIA COLI;

EID: 0344527836     PISSN: 0178515X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004490050567     Document Type: Article

References (18)

1. 1. Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7,316 cancer patients. J Am Acad Dermatol 1990; 22: 19.
2. 2. Reichel M, Wheeland RG. Inflammatory carcinoma masquerading as erythema annulare centrifugum. Acta Derm Venereol (Stockh) 1993; 73: 138.
3. 3. Tan BB, Marsden JR, Sanders DSA. Melanoma erysipeloides: inflammatory metastatic melanoma of the skin. Br J Dermatol 1993; 129: 327.
4. 4. Zala L, Jenni C. Das carcinoma erysipelatodes. Dermatologica 1980; 160: 80.
5. 5. Hazelrigg DE, Rudolph AH. Inflammatory metastatic carcinoma. Carcinoma erysipelatoides. Arch Dermatol 1977; 113: 69.
6. 6. Lucas FV, Pérez-Mesa C. Inflammatory carcinoma of the breast. Cancer 1978; 41: 1595.
7. 7. Finkel LJ, Griffiths CEM. Inflammatory breast carcinoma (carcinoma erysipeloides): an easily overlooked diagnosis. Br J Dermatol 1993; 129: 324.
8. 8. Ando K, Goto Y, Kato K, Murase T, Matsumoto Y, Ohaashi M. Zosteriform inflammatory metastatic carcinoma from transitional cell carcinoma of the renal pelvis. J Am Acad Dermatol 1994; 31: 284.
9. 9. Haupt HM, Hood AF, Cohen MH. Inflammatory melanoma. J Am Acad Dermatol 1984; 10: 52.
10. 10. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4,020 patients. J Am Acad Dermatol 1993; 29: 228.
11. 11. Álvarez-Mon M, Camacho F, Díaz Pérez JL, et al. Panorámica actual del melanoma. Madrid: Acción Médica, 1997.
12. 12. Requena L, Sánchez Yus E, Núñez C, White CR Jr, Sangueza OP. Epidermotropically metastatic breast carcinomas. Rare histopathologic variants mimicking melanoma and Paget's disease. Am J Dermatopathol 1996; 18: 385.
13. 13. Aguilar A, Schoendorff C, López Redondo MJ, Ambrojo P, Requena L, Sánchez Yus E. Epidermotropic metastases from internal carcinomas. Am J Dermatopathol 1991; 13: 452.
14. 14. Sau P, Solis J, Lupton GP, James WD. Pigmented breast carcinoma. A clinical and histopathological simulator of malignant melanoma. Arch Dermatol 1989; 125: 536.
15. 15. Poiares-Baptista A, Abreu de Vasconcelos A. Cutaneous pigmented metastasis from breast carcinoma simulating malignant melanoma. Int J Dermatol 1988; 27: 124.
16. 16. Dwarakanath S, Lee AKC, DeLellis RA, Silverman ML, Frasca L, Wolfe HJ. S-100 protein positivity in breast carcinomas: a potential pitfall in diagnostic immunohistochemistry. Hum Pathol 1987; 18: 1144.
17. 17. Bonetti F, Colombari R, Manfrin E, et al. Breast carcinoma with positive results from melanoma marker (HMB-45). Am J Clin Pathol 1989; 92: 491.
18. 18. Bacchi CE, Gown AM. Specificity of antibody HMB-45. Arch Pathol Lab Med 1992; 116: 899.